aldhehyde dehydrogenase family 5, subfamily A1
| GO Term | Evidence Code | PMID |
|---|---|---|
| succinate metabolic process | ||
| succinate metabolic process | ||
| succinate metabolic process | ||
| glutamate metabolic process | ||
| central nervous system development |
| GO Term | Evidence Code | PMID |
|---|---|---|
| mitochondrion | ||
| mitochondrion | ||
| mitochondrion | ||
| mitochondrion | ||
| synapse |
| GO Term | Evidence Code | PMID |
|---|---|---|
| succinate-semialdehyde dehydrogenase (NAD+) activity | ||
| succinate-semialdehyde dehydrogenase (NAD+) activity | ||
| succinate-semialdehyde dehydrogenase (NAD+) activity | ||
| carboxylic acid binding | ||
| identical protein binding |
| Gene Ontology |
|---|
| oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor |
| oxidoreductase activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:1826 | epilepsy |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026